aspirin and glp 1 Dr Jones on the Rationale for Comparing CRC Risk Reduction With GLP-1 Agonists vs GLP-1s More Effective at Preventing

GI side effects affect most users early on but are transient, nausea peaks during dose escalation and fades as your body adapts Semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) have the highest nausea rates

Tips to reduce body aches on a GLP-1 medication For most people, body aches are manageable with some simple lifestyle adjustments

Some studies have examined whether berberine might influence GLP-1 secretion through effects on the gut microbiome and intestinal cells

The speed of the development pipeline only adds to the challenge as GLP1 therapies are being used for approved indications beyond diabetes and obesity, including heart, liver and renal disease

Your provider should know if bloating prevents adequate nutrition, causes persistent discomfort, or triggers treatment discontinuation

Patients should contact their GP or prescribing clinician if they experience: Severe or persistent cramps that do not respond to simple measures or significantly impact daily activities and sleep quality Frequent cramping occurring multiple times daily or nightly Associated symptoms such as muscle weakness, numbness, tingling, or changes in sensation, which may indicate neurological involvement Visible muscle changes including swelling, redness, tenderness, or asymmetry between legs Signs of dehydration such as dizziness, reduced urine output, dark urine, or confusion These features may indicate underlying conditions requiring investigation, such as significant electrolyte disturbances, peripheral neuropathy (particularly relevant in diabetes), peripheral arterial disease, or, rarely, more serious muscle disorders